Liminatus Pharma Says Common Stock Transferred To Nasdaq Capital Market Effective August 4; Nasdaq Panel Grants Extension Until September 3 To Regain Minimum Bid Price Compliance

Loading news article.

Liminatus Pharma Says Common Stock Transferred To Nasdaq Capital Market Effective August 4; Nasdaq Panel Grants Extension Until September 3 To Regain Minimum Bid Price Compliance | WAPE

Liminatus Pharma Says Common Stock Transferred To Nasdaq Capital Market Effective August 4; Nasdaq Panel Grants Extension Until September 3 To Regain Minimum Bid Price Compliance

Article summary

Related companies

Comments —